Clinical Trial Update: Impact of Gastric Bypass Surgery on Risk of CVD in Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether gastric bypass surgery reduces cardiovascular disease risk in patients with obesity and type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Vanderbilt University | Conditions: Obese Patients, Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED